TMS Co., Ltd. (TSE: 4891)
Health Care · Biotechnology · JP
¥132.00
+0.76% today · -10.8% 1Y
TMS Co., Ltd. (TSE: 4891) operates in the Biotechnology industry within the Health Care sector. The company is valued at $38.44M and employs 18 people.
Over the last twelve months the share price has lost 10.8%, trading between 92.00 and 165.00.
Tweenvest scores TMS Co., Ltd. across four factors: quality 61/100, value 61/100. Its strongest factor is quality.
4891 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $38.44M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -15.99
- Dividend yield
- —
- Beta (5Y)
- 0.38
- 52-week high
- ¥165.00
- 52-week low
- ¥92.00
- Avg volume (3M)
- —
- Shares outstanding
- 45.67M
- Employees
- 18
- Next earnings
- —
About TMS Co., Ltd.
Established in 2005 and headquartered in Fuchu, Japan, TMS Co., Ltd. focuses on the research, development, manufacturing, and commercialization of pharmaceuticals, quasi-drugs, drug substances, medical devices, and various medical commodities. The company's pipeline includes TMS-007, an SMTP congener demonstrating both prothrombolytic and anti-inflammatory/antioxidative activities, which has advanced through Phase 2a clinical trials for the treatment of acute ischemic stroke. Additionally, TMS-008, another SMTP congener with anti-inflammatory/antioxidative properties, is undergoing nonclinical development for addressing inflammatory complications like acute kidney injury and cancer cachexia. A third product candidate, TMS-009, is currently in preclinical development. TMS Co., Ltd. collaborates with Hokkaido University and Kanazawa University to assess the potential of its drug candidates, has a joint research agreement with Teikyo University to identify renal function biomarkers, and maintains a strategic alliance with Ji Xing Pharmaceuticals Limited.
- ISIN
- JP3544960002
- Founded
- 2005
- Listed since
- Nov 22, 2022
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| TegoScience Inc.KOSDAQ: A191420 | $40.24M | ₩6,700.00 | -5.63% |
| Instil Bio, Inc.NasdaqCM: TIL | $40.08M | $5.91 | -12.31% |
| Genomics BioSci & Tech. Co.,Ltd.TWSE: 4195 | $38.71M | NT$15.70 | -3.68% |
| ME Therapeutics Holdings Inc.CNSX: METX | $38.53M | CA$1.80 | -35.71% |
| J2KBIO Co., Ltd.KOSDAQ: A420570 | $38.16M | ₩8,700.00 | -8.52% |
| eXoZymes, Inc.NasdaqCM: EXOZ | $37.96M | $4.09 | -22.10% |
| BrightPath Biotherapeutics Co., Ltd.TSE: 4594 | $37.83M | ¥43.00 | -4.44% |
| Sprint Bioscience AB (publ)OM: SPRINT | $37.82M | Skr3.55 | -2.74% |
Figures last refreshed Oct 18, 2026.